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Otitis media (OM) is a broad term describing a group of infectious and inflammatory
disorders of the middle ear. Despite antibiotic therapy, acute OM can progress
to chronic suppurative otitis media (CSOM) characterized by ear drum perforation
and purulent discharge. Pseudomonas aeruginosa is the most common pathogen
associated with CSOM. Although, macrophages play an important role in innate immune
responses but their role in the pathogenesis of P. aeruginosa-induced CSOM is not
known. The objective of this study is to examine the interaction of P. aeruginosa with
primary macrophages. We observed that P. aeruginosa enters and multiplies inside
human and mouse primary macrophages. This bacterial entry in macrophages requires
both microtubule and actin dependent processes. Transmission electron microscopy
demonstrated that P. aeruginosa was present in membrane bound vesicles inside
macrophages. Interestingly, deletion of oprF expression in P. aeruginosa abrogates
its ability to survive inside macrophages. Our results suggest that otopathogenic
P. aeruginosa entry and survival inside macrophages is OprF-dependent. The survival
of bacteria inside macrophages will lead to evasion of killing and this lack of
pathogen clearance by phagocytes contributes to the persistence of infection in CSOM.
Understanding host–pathogen interaction will provide novel avenues to design effective
treatment modalities against OM.
Keywords: otopathogenic P. aeruginosa, monocyte-derived macrophages, mouse bone marrow-derived
macrophages, cell viability
INTRODUCTION
Innate immune system serves as the first-line of defense against invading pathogens during
infection (Alberts et al., 2002; Clarke, 2014). One of the principal components of the innate
immune system are macrophages (Tam and Aderem, 2014; Divangahi et al., 2015; Hume, 2015;
Schultze et al., 2015). They are considered as “professional phagocytes” that play a crucial role in
eradication of pathogens through phagocytosis leading to clearance of infection (Aderem, 2003).
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Stimuli like infections lead to activation of macrophages.
In addition, they can rapidly attract neutrophils, monocytes
and other immune cells from the blood and hematopoietic
tissues to the site of infection by the release of cytokines and
chemotactic substances (Zhang and Wang, 2014). This leads
to an efficient orchestration of both innate and adaptive host
immune responses. Given the prominent role of macrophages
as an effector cell type in the host immune responses, it is not
surprising that certain pathogens have evolved strategies to evade
killing and use macrophages as a shield against cell-mediated and
humoral immune responses to cause infection in humans. Some
pathogens inhibit phagocytosis and subsequently activation of
macrophages (Fällman et al., 2002). However, no information is
available regarding host–pathogen interplay in the pathogenesis
of otitis media (OM).
Otitis media refers to any inflammatory or infectious process
involving the middle ear (Cunningham et al., 2012; Minovi
and Dazert, 2014; Atkinson et al., 2015; Wallis et al., 2015).
Chronic suppurative OM (CSOM) is a chronic inflammation of
the middle ear characterized by persistent middle ear drainage
through the perforated tympanic membrane for more than
6 weeks (Bluestone, 1998; Qureishi et al., 2014; Mittal et al., 2015).
The most common cause of CSOM is the bacterial infection
(Meyerhoff, 1988; Mittal et al., 2015). Pseudomonas aeruginosa is
one of the leading causes of CSOM (Yeo et al., 2007; Dayasena
et al., 2011; Madana et al., 2011; Afolabi et al., 2012). CSOM
is one of the largest public health burdens worldwide leading
to hearing loss and life-threatening central nervous system
complications, including brain abscess and meningitis (Chew
et al., 2012; Yorgancı lar et al., 2013; Sun and Sun, 2014). There
is an urgent need to develop new therapies to combat this disease
and help prevent complications associated with it. Understanding
the role of host immunity in the pathogenesis of CSOM will
open up novel avenues of treatment against the disease other than
antibiotics.
Macrophages are an integral component of innate immunity
and provide efficient protection against pathogens; however, the
role of macrophages in CSOM has not been elucidated. In this
study, we characterized the interaction of otopathogenic
P. aeruginosa with primary human monocyte-derived
macrophages (MDMs) and mouse bone marrow-derived
macrophages (BMMφ), in vitro. Our data suggests that
otopathogenic P. aeruginosa enters and survives inside human
MDMs and mouse BMMφ. Since bacterial outer membrane
proteins (OMPs) play a crucial role in interaction of pathogens
with immune cells (Confer and Ayalew, 2013), we determined
the role of P. aeruginosa OprF in bacterial survival inside
macrophages. OprF is the major OMP of P. aeruginosa and
has been demonstrated to play an important role in interaction
of this pathogen with host cells (Nestorovich et al., 2006;
Bouffartigues et al., 2012; Reusch, 2012; Mishra et al., 2015).
We observed that survival of otopathogenic P. aeruginosa inside
macrophages requires bacterial oprF expression. The ability
of P. aeruginosa to survive inside macrophages enables it to
escape killing by potent host immune responses and this lack
of clearance by phagocytes contributes to the persistence of
infection in CSOM.
MATERIALS AND METHODS
Cell Culture
Mouse BMMφ were generated by harvesting bone marrow cells
from murine tibias and femurs as described earlier (Godek
et al., 2006; Weischenfeldt and Porse, 2008). Briefly, bone
marrow cells were flushed from mouse bones (C57 BL6), and
then differentiated into a macrophage phenotype by incubating
in complete DMEM (cDMEM, 10% heat inactivated fetal
bovine serum (FBS, Hyclone R©, Logan, UT, USA), 30% L-929
fibroblast conditioned medium, 1% penicillin–streptomycin
(Gibco, Carlsbad, CA, USA), 0.01 M Hepes buffer, 1 mM sodium
pyruvate, and 1% of a × 100 MEM non-essential amino acids
solution (all from Sigma, St. Louis, MO, USA) in Dulbecco’s
modified Eagle’s medium (DMEM, Mediatech, Herndon, VA,
USA). Cells were differentiated for 7 days with media changes
every 2 days. This study was carried out in accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health (NIH).
The protocol was approved by the Institutional Animal Care and
Use Committee (IACUC) of the University of Miami.
Human MDMs were generated by separating monocytes
from peripheral blood obtained from healthy blood donors, as
previously described (Welin et al., 2008; Eklund et al., 2010; Meng
et al., 2015; Shinzaki et al., 2016). Donors were between age
groups of 25–50 years, of either sex and were free from blood-
borne diseases. In brief, monocytes were obtained by layering
blood onto a density gradient, followed by centrifugation and
isolation of the monocyte/lymphocyte fraction. Cells were seeded
in culture flasks and allowed to adhere for 2 h before non-
adherent lymphocytes were washed away. The monocytes were
allowed to differentiate into human MDMs for 5–8 days in
DMEM (Gibco, Carlsbad, CA, USA) containing 25 mM Hepes,
100 U/ml penicillin, 100 µg/ml streptomycin and 10% active
human serum (all Sigma, St. Louis, MO, USA). All cell cultures
were incubated under 37◦C, 5% CO2, 98% humidity. Human
whole blood was obtained from commercial vendors including
Interstate blood bank and followed NIH guidelines for the
protection of human subjects including informed signed consent
from all subjects by these vendors. All the information regarding
human subjects was deidentified and investigators were having
no access to any human subject information. The institutional
review board (IRB) of the University of Miami approved the
study protocol.
Bacterial Strains
The clinical strains of P. aeruginosa (10 strains) isolated from
CSOM patients attending University of Miami Hospital or
Hospital for Rehabilitation of Craniofacial Anomalies of the
University of São Paulo, Bauru, Brazil were used in this study.
The patients exhibited persistent chronic purulent otorrhoea
through perforated tympanic membrane for more than 6 weeks
confirmed by otolaryngologic diagnosis. The isolation and
identification of P. aeruginosa was performed using standard
methods (MacFaddin, 1976; Forbes et al., 1998). The oprF mutant
and complemented strain of P. aeruginosa was generated as
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described in previous studies (Woodruff and Hancock, 1989;
Horton et al., 1990; Schweizer and Hoang, 1995; Rietsch et al.,
2005; Balasubramanian et al., 2012; Yakhnina et al., 2015)
(Supplementary Materials). Bacteria were grown overnight at
37◦C in Luria broth (LB) (Teknova, Hollister, CA, USA) in a
rotary shaker.
Invasion Assays
Gentamicin protection assays were used to quantify the extent
of human MDM and mouse BMMφ invasion and survival by
otopathogenic P. aeruginosa. Briefly, cells were infected with
bacteria at 1:1, 5:1, 10:1, 25:1, 50:1, 100:1 multiplicity of infection
(MOI) (bacteria:cell) for 1, 2, 4, and 6 h. After incubation, the cells
were washed five times with warm RPMI medium (Corning, NY,
USA) followed by addition of medium containing gentamicin
(200 µg/ml) (Life Technologies, Carlsbad, CA, USA) and further
incubated for 1 h at 37◦C. All P. aeruginosa isolates we used in
this study were sensitive to gentamicin at this concentration. The
cells were washed three times with RPMI and then lysed with
1% saponin (Sigma, St. Louis, MO, USA) to release intracellular
bacteria. Serial dilutions were then plated on blood agar plates
and bacterial colonies were counted the next day. In some
experiments, bacteria were pretreated with 20% human or mouse
pooled serum or heat inactivated pooled serum and then used
to infect human MDMs and mouse BMMφ, respectively. In
some experiments, bacteria were pretreated with monoclonal
anti-OprF antibody (kindly provided by Dr. Hancock) and then
used in the invasion assay. The monoclonal antibody (mAb)
was specific to surface epitopes of OprF and was generated as
described previously (Finnen et al., 1992; Rawling et al., 1995).
To determine the effect of cytoskeletal inhibitors, macrophages
were pretreated with different concentrations of cytochalasin
D, vinblastine, nocodazole, or colchicine (all from Sigma, St.
Louis, MO, USA) for 30 min before infecting with bacteria, and
maintained in the medium for the entire infection period.
Scanning Electron Microscopy (SEM)
Human MDMs and mouse BMMφ were cultured on glass cover
slips and were infected with bacteria for 30 min to 8 h. After
incubation, the cells were washed five times with warm phosphate
buffer saline (PBS) buffer (Sigma, St. Louis, MO, USA) to remove
unbound bacteria and were then processed for scanning electron
microscopy (SEM). Samples were fixed in 2% glutaraldehyde
(Electron Microscopy Sciences, Hatfield, PA, USA) in PBS buffer
followed by three changes of PBS buffer for 10 min each. The
samples were then post-fixed in 1% osmium tetroxide (Electron
Microscopy Sciences, Hatfield, PA, USA) in PBS buffer for 45 min
and rinsed in three changes of PBS buffer for 10 min each. The
samples were dehydrated in a graded series of ethanol, dried in
hexamethyldisilazane (HMDS) (Electron Microscopy Sciences,
Hatfield, PA, USA) and mounted on carbon adhesive tabs fixed to
metal stubs. The samples were coated with palladium in a plasma
sputter coater and viewed in a SEM (FEI, ESEM-FEG XL-30).
Transmission Electron Microscopy (TEM)
Human MDMs and mouse BMMφ were infected with bacteria
for 30 min to 8 h. After incubation, the cells were washed with
PBS and fixed using 2% glutaraldehyde (Electron Microscopy
Sciences, Hatfield, PA, USA). The samples were rinsed in
three washes of PBS buffer then post-fixed in 1% osmium
tetroxide (Electron Microscopy Sciences, Hatfield, PA, USA)
in 0.1 M phosphate buffer for 1 h. After buffer rinses,
specimens were dehydrated through a series of graded ethanol,
placed in two rinses of propylene oxide (Electron Microscopy
Sciences, Hatfield, PA, USA) for 5 min each and then put
in a 1:1 mixture of propylene oxide: EMbed/Araldite resin
(Electron Microscopy Sciences, Hatfield, PA, USA) for overnight
incubation at room temperature. Next day, the pellets were placed
in fresh EMbed/Araldite and put in a vacuum desiccator for
2–4 h. The samples were changed to fresh EMbed/Araldite and
polymerized overnight. Silver/gold sections were then cut on a
Leica Ultracut E (Leica, Buffalo Grove, IL, USA), stained in uranyl
acetate (Electron Microscopy Sciences, Hatfield, PA, USA) and
lead citrate (Electron Microscopy Sciences, Hatfield, PA, USA),
and viewed in a JEOL 1400 electron microscope (JEOL, Peabody,
MA, USA) with Gatan Orius SC1000 camera (Gatan, Pleasanton,
CA, USA).
Immunofluorescence
For staining of bacteria and actin, human MDMs and mouse
BMMφ were cultured in 8-well chamber slides and infected
with P. aeruginosa for 30 min to 8 h. After incubation, cells
were washed three times with PBS buffer and then fixed
and permeabilized with BD cytofix and cytoperm reagent (BD
Biosciences, San Jose, CA, USA) for 30 min. After washing,
the cells were blocked with 3% normal goat serum (NGS) (Life
Technologies, Carlsbad, CA, USA) for 20 min and then incubated
with anti-P. aeruginosa antibody (1:200) (Abcam, Cambridge,
MA, USA) for 45 min followed by Alexa Fluor 488 antibody
(1:1000) (Life Technologies, Carlsbad, CA, USA). After washing,
cells were counterstained for actin with rhodamine phalloidin
(Life Technologies, Carlsbad, CA, USA) for 45 min, washed
and mounted in an antifade Vectashield solution containing
4, 6-diamidino-2-phenylindole (DAPI) (Vector Laboratories,
Burlingame, CA, USA). The cells were viewed with a Zeiss
LSM 710 microscope (Carl Zeiss, Germany) and images were
assembled using Adobe photoshop 7.0.
Cell Viability
To evaluate the cytotoxic effects of P. aeruginosa on human
MDMs and mouse BMMφ during the course of infection, cells
were seeded in 96 well plates and infected with bacteria for
2–24 h at an MOI of 10. Lactate dehydrogenase (LDH) levels were
then determined in cell culture supernatants using commercially
available kit, as per the manufacturer’s instructions (Cayman
Chemical, Ann Arbor, MI, USA). Uninfected cells were included
as negative control. Maximum LDH release induced by treatment
of macrophages with 1% Triton X-100 (Sigma, St. Louis, MO,
USA) was used as a positive control. Results were expressed as
percentage LDH release compared to the positive control.
The viability of P. aeruginosa infected human MDMs and
mouse BMMφ was also determined by ethidium homodimer-1
staining (Eidet et al., 2015; McCanna et al., 2015; Yoeruek et al.,
2016). Ethidium homodimer-1 enters inside dead cells through
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the disrupted plasma membrane and binds to nucleic acids that
increase its fluorescence intensity leading to the production of red
fluorescence. Live cells exclude ethidium homodimer-I staining
due to the intact plasma membrane. Human MDMs and mouse
BMMφ were infected with bacteria for 2–24 h time periods at
an MOI of 10 and then stained with ethidium homodimer-1.
Fluorescence was then determined using a microplate reader
with appropriate filters (excitation at 535 nm and emission at
620 nm). The percentage dead cells were then calculated using
the following formula:
%Dead Cells = [F(620 nm)sample − F(620 nm)minimum]
× 100/[F(620 nm)maximum − F(620 nm)minimum]
where F(620 nm) is fluorescence intensity at a wavelength
of 620 nm, F(620 nm)sample is fluorescence intensity of
human MDMs and mouse BMMφ infected with P. aeruginosa,
F(620 nm)minimum is fluorescence intensity of uninfected
human MDMs and mouse BMMφ, and F(620 nm)maximum is
fluorescence intensity of human MDMs and mouse BMMφ
treated with 1% Triton X-100 (Sigma, St. Louis, MO, USA).
Statistical Analysis
Statistical significance was determined by a paired, two-tailed
Student’s t-test and ANOVA using SPSS software. Values of
P < 0.05 were considered to be statistically significant.
RESULTS
Otopathogenic P. aeruginosa Enters and
Survives Inside Primary Human MDMs
and Mouse BMMφ
Since P. aeruginosa is the major etiological agent of CSOM, we
hypothesize that this pathogen hijacks host innate immunity
that forms the first line of defense. To test this hypothesis, we
examined the ability of a clinical isolate of P. aeruginosa from
CSOM patient to enter and survive inside primary human and
mouse macrophages by gentamicin protection assay at different
MOIs for 2 h. We observed that P. aeruginosa is able to enter
and survive inside macrophages. At an MOI of 1, log 1.45
colony forming unit (cfu) bacteria were recoverable from human
MDMs whereas log 1.12 cfu bacteria were demonstrable inside
mouse BMMφ (Figure 1a). The number of bacteria inside human
MDMs increased from 2.23 to 4.11 log cfu with a corresponding
increase in MOI from 5 to 10 (Figure 1a). Similar increase in
number of bacteria was observable inside mouse BMMφ. The
number of bacteria increased from log 2.11 log cfu at an MOI
of 5 to log 3.48 cfu at an MOI of 10 (Supplementary Figure
S1a). Further increase in MOI to 25, 50, and 100 caused only
marginal increase in number of bacteria inside human MDMs
and mouse BMMφ (P > 0.05). Therefore, we selected a MOI of
10 and post-infection time period of 2 h for further experiments.
In order to determine the effect of increasing infection time on
the cell invasion, macrophages and P. aeruginosa were incubated
FIGURE 1 | Otopathogenic Pseudomonas aeruginosa enters and
survives inside macrophages. Human MDMs were infected with a clinical
isolate of P. aeruginosa for 2 h and intracellular survival was determined by
gentamicin protection assay (a). In separate experiments, human MDMs were
infected with P. aeruginosa at different MOIs for 1–8 h and phagocytosis was
determined (b). Data represents mean ± SD and is representative of five
individual experiments carried out in triplicate. ∗P < 0.01 or #P > 0.05 by
Student’s t-test and ANOVA.
for several time-points. By 1 h post-infection time period, 1.04
log cfu bacteria were demonstrable inside human MDMs that
increased to 2.96 log cfu bacteria by 8 h post-infection at an
MOI of 1 (Figure 1b). At an MOI of 5 and 10, there were 1.56
and 2.12 log cfu bacteria at 1 h post-infection that increased
to 3.39 and 6.98 at 8 h post-infection time period respectively.
At a high MOI of 100, 7.55 log cfu bacteria were recoverable
from human MDMs at 8 h post-infection time period. Mouse
BMMφ also demonstrated increase in bacterial load with the
corresponding increase in post-infection time period from 1 to
8 h at all MOIs (Supplementary Figure S1b). Similar results of
human MDM and mouse BMMφ invasion was observed with
nine additional P. aeruginosa CSOM clinical isolates at an MOI
of 10 (Supplementary Figures S2 and S3). There was increase in
bacterial load in both human MDMs and mouse BMMφ with
increase in post-infection time period from 2 to 6 h. Taken
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together, these results suggest that otopathogenic P. aeruginosa
invades human MDMs and mouse BMMφ in a time and dose
dependent manner.
Opsonization Has No Effect on the
Invasion of Macrophages by
P. aeruginosa
Complement proteins are constitutively present in the serum
and can opsonize bacteria non- specifically promoting pathogen
killing and clearance of infection (Daha, 2010; Merle et al.,
2015; Varela and Tomlinson, 2015). Therefore, we evaluated
whether complement affects the phagocytosis of P. aeruginosa
by macrophages. To determine the effect of opsonins on the
survival of P. aeruginosa, two CSOM bacterial isolates were
opsonized with fresh normal or heat-inactivated human or mouse
pooled serum or were treated with medium alone prior to
infection of human MDMs and mouse BMMφ. Interestingly,
there was no statistical difference in the number of non-
opsonized and opsonized bacteria in human MDMs and mouse
BMMφ (P > 0.05; Figures 2a,b). The heat-inactivated serum
also had no significant effect on the ability of otopathogenic
P. aeruginosa to invade macrophages (P > 0.05). These results
suggest that complement did not play a significant role in
invasion of human MDMs and mouse BMMφ by P. aeruginosa.
Ultrastructural Examination of
P. aeruginosa Infected Human MDMs
and Mouse BMMφ
To examine the interaction of P. aeruginosa with macrophages
in detail, human MDMs and mouse BMMφ were subjected to
SEM. During the first 15 min of post-infection, P. aeruginosa
was observed to adhere to human MDMs through pseudopod
like structures (Figure 3a). There was an increase in the
formation of these pseudopod like structures at 30 min post-
infection (Figure 3b). Bacteria were seen to be adhered to the
human MDMs mostly in clusters. However, individually attached
bacteria were also observed. By 1 h post-infection, few bacteria
were demonstrable on the surface of human MDMs accompanied
with membrane ruﬄing (Figure 3c). The number of bacteria on
the surface of human MDMs increased with increase in post-
infection time period (Figures 3d,e). A large number of bacteria
were observed on the surface of macrophages by 8 h post-
infection (Figure 3f). Similarly few bacteria were demonstrable
on the surface of mouse BMMφ at 60 min post-infection that
increased in number with increase in post-infection time period
to 8 h. As observed with human MDMs, we also observed
pseudopod formation and membrane ruﬄing in P. aeruginosa
infected mouse BMMφ (Supplementary Figure S4).
Transmission electron microscopy (TEM) demonstrated that
human MDMs form plasma membrane protrusions in response
to P. aeruginosa infection that can act as bacterial adhesion
sites (Figure 4a). The bacteria were found in the enclosed
membrane protrusions by 30 min post-infection in human
MDMs (Figure 4b). At 60 min post-infection, P. aeruginosa
was internalized into human MDMs inside membrane bound
vacuoles (Figure 4c). In some vacuoles, the membrane was
FIGURE 2 | Bacterial opsonization has no significant effect on
internalization of P. aeruginosa by macrophages. Otopathogenic
P. aeruginosa isolates (OM7 and OM15) were pretreated with 20% pooled
human serum (PHS) or pooled mouse serum (PMS) or heat-inactivated serum
(HI-PHS or HI-PMS) or left untreated (control) and then used to infect human
MDMs (a) and mouse BMMφ (b). The invasion of macrophages by bacteria
was then determined by gentamicin protection assay. Results were expressed
as percentage invasion relative to control group. Data represents mean ± SD
and is representative of four individual experiments carried out in triplicate.
#P > 0.05 compared to control by Student’s t-test and ANOVA.
closely apposed to the bacteria whereas in others there was a
space between bacteria and the membrane. In addition, actively
dividing bacteria inside human MDMs were also observed
(Figure 4d). There was increase in bacterial number inside
human MDMs at 2 h post-infection (Figure 4e). At 4 h
post-infection, the vacuoles containing bacteria increased in
size (Figure 4f). At 8 h post-infection, there was clustering
of bacteria inside human MDMs. In some vacuoles, multiple
bacteria were demonstrable inside them (Figure 4g). At this post-
infection time-period, P. aeruginosa disrupted the membrane and
many free bacteria were observed in the cytoplasm of human
MDMs (Figure 4h). Mouse BMMφ displayed similar phenotypic
changes in response to otopathogenic P. aeruginosa infection
(Supplementary Figure S5).
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FIGURE 3 | Scanning electron micrographs of human MDMs infected
with P. aeruginosa. Human MDMs were infected with P. aeruginosa for
15 min (a), 30 min (b), 1 h (c), 2 h (d), 4 h (e), and 8 h (f) and subjected to
SEM. We observed that P. aeruginosa (green arrows) attach to pseudopod
like structures (yellow arrows) on human macrophages. Results are
representative of three individual experiments. Scale bars 2 µm.
Entry of Otopathogenic P. aeruginosa Is
Dependent on Both Microfilament and
Microtubule Associated Pathway
Host cytoskeleton can play a crucial role in bacterial cell invasion.
Therefore, we determined whether invasion of macrophages by
P. aeruginosa relies on microfilament and microtubule dependent
pathways. Human MDMs and mouse BMMφ were infected
with P. aeruginosa in the presence of increasing concentrations
of cytochalasin D, an inhibitor of actin polymerization. There
was a significant dose-dependent decrease in the invasion of
human MDMs and mouse BMMφ in the presence of cytochalsin
D compared to DMSO treated or untreated cells (P < 0.01)
(Figure 5a). A 30% decrease in invasion in the presence of
2 µM cytochalasin D was observed whereas 90% decrease
in invasion was observable at a concentration of 20 µM in
human MDMs (Figure 5a). Microtubule disrupting compounds,
vinblastine, colchicine, and nocodazole also caused a dose-
dependent decrease in the invasion of human MDMs by
P. aeruginosa (P < 0.01). Human MDMs pretreated with 10 µM
vinblastine showed 40% decrease in invasion whereas cells
pretreated with 50 µM demonstrated more than 90% decrease in
invasion compared to DMSO treated or untreated macrophages
(Figure 5b). Colchicine caused an 80% decreased in invasion at a
concentration of 25 µM, whereas a 95% decrease in invasion was
FIGURE 4 | Transmission electron micrographs demonstrating
phagocytosis of P. aeruginosa by macrophages. Human MDMs were
infected with P. aeruginosa for 15 min (a), 30 min (b), 1 h (c,d), 2 h (e), 4 h (f),
and 8 h (g,h) and subjected to TEM. Bacteria were demonstrable inside
membrane bound vacuoles in human MDMs which eventually were disrupted
by 8 h post-infection. Yellow arrows indicate pseudopod like structures and
green arrows indicate bacteria. Results are representative of three individual
experiments. Scale bars (a,c–h) 2 µm; (b) 1 µm.
observed in the presence of 30 µM nocodazole (Figures 5c,d).
Similar significant decrease in invasion of mouse BMMφ
was observed in the presence of cytochalsin D, vinblastine,
colchicine, and nocodazole (P < 0.01) (Figures 5a–d). We
observed that there were no toxic effects of these reagents
on bacteria or on cells at the tested concentrations (data
not shown). These results with inhibitory compounds suggest
that P. aeruginosa invades human MDMs and mouse BMMφ
through both microfilament and microtubule dependent uptake
mechanisms.
P. aeruginosa Induces Actin
Cytoskeleton Rearrangements during
Invasion of Macrophages
Actin cytoskeleton rearrangement is a common strategy
employed by pathogens to invade host cells (Yang et al., 2012;
Navarro-Garcia et al., 2013; de Souza Santos and Orth, 2015;
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FIGURE 5 | Macrophages phagocytose P. aeruginosa through microfilament and microtubule dependent uptake mechanisms. Human MDMs or mouse
BMMφ were pretreated with cytochalasin D (a), vinblastine (b), colchicine (c), and nocodazole (d) and then infected with P. aeruginosa. Phagocytosis of
P. aeruginosa by macrophages was determined by gentamicin protection assay. Data represents mean ± SD and is representative of four individual experiments
carried out in triplicate. ∗P < 0.01 compared to control by Student’s t-test and ANOVA.
Zheng et al., 2015). To determine whether P. aeruginosa
induces alterations to the cytoskeleton during invasion of
human MDMs and mouse BMMφ, the distribution of F-actin
in macrophages was examined. Human MDMs and mouse
BMMφ were infected with P. aeruginosa and stained with
rhodamine phalloidin to detect F-actin. Uninfected human
MDMs showed spatial distribution of F-actin throughout the
cell (Figures 6a–d). However, infected human MDMs showed
actin condensation in response to otopathogenic P. aeruginosa
infection (Figure 6). At 30-min post-infection, a lot of actin
accumulation underneath the bacterial binding sites was
observed (Figures 6e–h). There was a lot of interaction of
bacteria with the actin filaments. At 60-min, there was further
increase in actin accumulation that colocalized with the bacteria
as indicated by the yellow color (Figures 6i–l). Similar pattern
of actin accumulation was observed in mouse BMMφ infected
with otopathogenic P. aeruginosa (data not shown). Taken
together, these findings suggest that P. aeruginosa induces
actin cytoskeleton rearrangements that facilitate its entry inside
macrophages.
Bacterial OprF Expression Plays a
Crucial Role in Invasion of Macrophages
by P. aeruginosa
Bacterial OMPs play a crucial role in interaction of pathogens
with host cells (Toma et al., 2014; Alzahrani et al., 2015; Bulir
et al., 2015). OprF is the major OMP/porin of P. aeruginosa
that has been demonstrated to facilitate biofilm formation under
anaerobic conditions and adhesion to host cells (Azghani et al.,
Frontiers in Microbiology | www.frontiersin.org 7 November 2016 | Volume 7 | Article 1828
fmicb-07-01828 November 16, 2016 Time: 14:6 # 8
Mittal et al. Interaction of Otopathogenic P. aeruginosa with Macrophages
FIGURE 6 | Pseudomonas aeruginosa induces actin cytoskeletal rearrangements during invasion of macrophages. Human MDMs were infected with
P. aeruginosa for 30 min (e–h) or 60 min (i–l) or left uninfected (a–d) and then stained with anti-P. aeruginosa antibody followed by Alexa Fluor 488 (green). Cells
were counterstained with rhodamine phalloidin to visualize actin (red) and DAPI for cell nuclei (blue). Results are representative of three individual experiments. Scale
bars 10 µm.
2002; Yoon et al., 2002). Therefore, we examined whether OprF
play a role in the invasion of macrophages by P. aeruginosa.
Both human and mouse macrophages were infected with wild-
type (WT), 1oprF and trans-complemented (pOprF) strains of
P. aeruginosa. At 2 h post-infection, there was no significant
difference (P > 0.05) in the phagocytosis of 1oprF mutant
strain of P. aeruginosa compared to WT or pOprF strains
(Figures 7a,b). However, the number of 1oprF bacterial mutant
decreased significantly inside both human MDMs and mouse
BMMφ at 4 h post-infection (P < 0.01). At 6 h post-infection,
no viable 1oprF bacteria were recoverable from human MDMs
and very low number of bacteria from mouse BMMφ. In contrast,
high numbers of bacteria were recoverable from WT or pOprF
infected human MDMs and mouse BMMφ.
To further confirm the role of OprF in invasion of
macrophages by P. aeruginosa, WT bacteria were pretreated
with anti-OprF monoclonal antibody or isotype control or
left untreated and then used to infect human MDMs and
mouse BMMφ. Pretreatment of bacteria with anti-OprF
monoclonal antibody significantly decreased the number of
bacteria recoverable from human MDMs at 4 and 6 h post-
infection compared to isotype control treated or untreated
bacteria (P < 0.01) (Figure 7c). Similar decrease in number
of intracellular P. aeruginosa was observed at 4 and 6 h post-
infection when pretreated bacteria were used to infect mouse
BMMφ (Figure 7d). These results suggest that OprF plays a
critical role in the survival of P. aeruginosa inside macrophages.
Otopathogenic P. aeruginosa Exerts
Cytopathic Effect on Macrophages
To determine whether infection of macrophages with
P. aeruginosa causes cell death. Human MDMs and mouse
BMMφ were infected with P. aeruginosa at an MOI of 10
and the levels of LDH released were determined in the cell
culture supernatants. LDH release is the most acceptable and
reliable marker to determine cell viability34−36. There was not
much cell damage up to 8 h post-infection as demonstrated by
minimal LDH release in cell culture supernatants of both human
MDMs and mouse BMMφ infected with WT otopathogenic
P. aeruginosa (Figures 8a,b). However, a further increase in time
resulted in significant cell death (P < 0.01). LDH levels increased
from 12.5% at 10 h post-infection to 46.7% by 16 h post-infection
in culture supernatants of infected human MDMs. Similarly,
LDH levels increased from 15.7% at 8 h post-infection to 39.8%
at 16 h post-infection in mouse BMMφ. At 24 h post-infection,
there was even a higher level of cell death, as indicated by high
LDH levels in human MDMs and mouse BMMφ. Interestingly,
deletion of oprF abrogated the ability of otopathogenic to induce
significant cell death in macrophages (P < 0.01). However,
complementation with the pOprF plasmid restored the ability of
mutant strain to exert cytopathic effects on human MDMs and
mouse BMMφ.
To further confirm that macrophages undergo apoptosis,
infected human MDMs and mouse BMMφ were stained with
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FIGURE 7 | Intracellular survival of P. aeruginosa inside macrophages requires bacterial oprF expression. Human MDMs and mouse BMMφ were infected
with wild-type (WT), 1oprF mutant or plasmid complemented (pOprF) strains of P. aeruginosa. Phagocytosis of bacteria by human MDMs (a) and mouse BMMφ (b)
was determined by gentamicin protection assay. In separate experiments, bacteria were pretreated with anti-oprF monoclonal antibody or left untreated and then
used to infect human MDMs (c) and mouse BMMφ (d). Results were expressed as percentage compared to the phagocytosis of the WT strain. Data represents
mean ± SD and is representative of four individual experiments carried out in triplicate. ∗P < 0.01 compared to control by Student’s t-test and ANOVA.
ethidium homodimer-1, a high affinity, membrane-impermeant
dye that exclusively stains the DNA of dead cells (Eidet et al.,
2015; McCanna et al., 2015; Yoeruek et al., 2016). In agreement
with the LDH assay results, at 8 h post-infection very little
ethidium homodimer-1 staining of infected human MDMs was
observed (P > 0.05) (Supplementary Figure S6). However, 25%
of human MDMs were stained with membrane-impermeant
dye at 10 h post-infection. At 16 h post-infection, 50% of
infected MDMs failed to exclude the dye. By 24 h post-infection,
almost 75% of human MDMs had been stained with ethidium
homodimer-1 suggesting considerable cell death. Similar results
were obtained with mouse BMMφ demonstrating extensive cell
death at 24 h post-infection (Supplementary Figure S6). On par
with our LDH data, human MDMs and mouse BMMφ infected
with 1oprF mutant strain did not demonstrate significant
ethidium homodimer-1 staining even at 24 h post-infection
compared to WT infected cells (P < 0.01). This phenotype
was restored upon complementation with pOprF. These results
suggest that otopathogenic P. aeruginosa exerts cytopathic effects
on macrophages for which bacterial OprF expression is necessary.
DISCUSSION
Despite advances in medical therapy, CSOM is still a clinically
challenging disease. Antibiotics are the only available
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FIGURE 8 | Otopathogenic P. aeruginosa affect viability of
macrophages. Human MDMs (a) or mouse BMMφ (b) were infected with
P. aeruginosa at an MOI of 10 and viability of the macrophages was
determined by measuring LDH levels in cell culture supernatants. Results
were expressed as the percentage compared with maximum LDH release by
lysed cells. Data represents mean ± SD and is representative of four individual
experiments carried out in triplicate. ∗P < 0.01 compared to WT or pOprF by
Student’s t-test and ANOVA.
treatment modalities against CSOM at present but these
have moderate efficacy against the disease, and at times
are not effective at all. The antibiotics used to treat CSOM
include neomycin, ciprofloxacin, cefepime, carbapenem,
levofloxacin, and ceftazidime (Saunders J. et al., 2011; Mittal
et al., 2015). However, P. aeruginosa has been demonstrated
to be resistant to a wide variety of antibiotics including
β lactams (penicillins, cephalosporins, and carbapenems),
fluoroquinolones (ciprofloxacin), polymyxins and macrolides
(erythromycin and azithromycin) (Nordmann and Guibert,
1998; Livermore, 2002; Walsh et al., 2003; Jang and Park, 2004;
Poole, 2004, 2011; Saunders J. et al., 2011; Morita et al., 2014;
Mittal et al., 2015). P. aeruginosa exhibits some degree of
sensitivity to aminoglycosides but this class of antibiotics has
significant ototoxicity and is not recommended for the treatment
of CSOM (Black et al., 2004; Jing et al., 2015; Koo et al., 2015; Leis
et al., 2015). A better knowledge of the interaction of pathogens
with immune cells will provide new opportunities to design
effective novel therapeutic strategies against CSOM. Although
immune cells play an important role in clearance of infection,
the interaction of otopathogenic P. aeruginosa with macrophages
has never been investigated. The results of the present study
contribute to our understanding of the interaction between
otopathogenic P. aeruginosa and primary macrophages.
Macrophages form an important line of host defense in
innate immune system against infections (Aderem, 2003;
Tam and Aderem, 2014; Zhang and Wang, 2014; Divangahi
et al., 2015; Hume, 2015; Schultze et al., 2015). Some studies
employ macrophage cell lines to understand the interaction
of pathogens with immune cells that may not mimic the
true characteristics of primary cells. These cell lines are
fundamentally different from the primary cells in that they
grow continuously in culture due to permanent alterations
in their genes. Such changes could have an effect on the
signaling cascades that are activated following interaction of
immune cells with pathogens. The results of studies utilizing
primary cells have been instrumental in developing our
understanding regarding immune cell response to infection.
Therefore, in the present study primary human MDMs and
mouse BMMφ have been used to investigate the interaction
between otopathogenic P. aeruginosa and macrophages. This
study for the first time demonstrated that otopathogenic
P. aeruginosa enters and survives inside primary human
MDMs and mouse BMMφ in a dose and time dependent
manner in context of ear infections. We also observed that
serum opsonization has no significant effect on invasion of
macrophages by P. aeruginosa. Since opsonization of pathogens
by serum components facilitate phagocytosis through Fc
gamma receptors on macrophages, these results suggest that
otopathogenic P. aeruginosa employs unique mechanisms to
enter inside macrophages. SEM demonstrated that otopathogenic
P. aeruginosa adheres to the primary macrophages through the
formation of pseudopod like structures. TEM confirmed the
internalization of bacteria inside human MDMs and mouse
BMMφ. We also observed that survival of otopathogenic
P. aeruginosa inside depends on the expression of OprF,
the most abundant bacterial OMP/porin. On par with these
findings, pretreatment of bacteria with anti-OprF monoclonal
antibody significantly decreased the invasion of macrophages
by P. aeruginosa, highlighting the crucial role of OprF in cell
invasion. The ability of otopathogenic P. aeruginosa to survive
inside macrophages provides protection against complement,
lysozyme activity and other host immune defenses. This enables
P. aeruginosa to evade killing and hence may constitute an
important virulence trait.
Macrophages are a preferred niche for certain pathogens
as they are highly phagocytic and long lived, providing
protection for a prolonged period. Pathogens including Candida
glabrata, Enterococcus faecalis, Brucella sp., Mycobacterium
tuberculosis, Escherichia coli and Group B streptococci,
have also been demonstrated to enter and survive inside
macrophages, which has been correlated with their ability to
cause infection (Valentin-Weigand et al., 1996; Cornacchione
et al., 1998; Pieters and Gatfield, 2002; Celli, 2006; Miramón
et al., 2013; Miskinyte and Gordo, 2013; Elliott et al., 2015;
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Kasper et al., 2015; Sabatino et al., 2015). Other pathogens
such as Yersinia spp. avoid uptake and phagocytosis preventing
activation of macrophages thus avoiding potent host immune
responses (Fällman et al., 2002). It has been demonstrated that
tyrosine phosphorylation plays a crucial role in phagocytosis
and subsequent activation of professional phagocytes (Park
et al., 2011). However, pathogens produce effector proteins
to neutralize tyrosine phosphorylation that promotes
inhibition of phagocytosis and activation of macrophages.
The effector protein, YopH, of Yersinia spp. possess tyrosine
phosphatase activity thus counteracting the activating tyrosine
phosphorylation signals of the host cell (Yuan et al., 2005).
This protein is delivered into host cells through bacterial
type III secretion system (T3SS) and prevents Yersinia
internalization by macrophages by dephosphorylating the
adaptor protein p130Cas, among other targets (Andersson
et al., 1996). Salmonella typhimurium secretes the tyrosine
phosphatase SptP, which is also injected into host cells
through a T3SS (Kaniga et al., 1996). SptP deactivates Rho-
family GTPases and subsequently abrogates activation of
macrophages. In addition, in case of adherent S. aureus, it has
been demonstrated that surface of biomaterial plays a crucial
role in bacterial phagocytosis by macrophages (Domingues
et al., 2015). S. aureus adhered to hydrophilic surfaces had a
lowest rate of phagocytosis while bacteria adhered to common
biomaterials such as silicone rubber, tissue culture polystyrene
and stainless steel has intermediate rate of phagocytosis by J774A
macrophage cell line. It was concluded that hydrophobicity
is a necessary surface condition for effective phagocytosis of
S. aureus by J774A macrophage cell line. Our previous studies
have demonstrated that P. aeruginosa can invade human
middle ear epithelial cells (HMEECs) (Mittal et al., 2014).
However, the interaction of otopathogenic P. aeruginosa with
primary macrophages has never been explored in previous
studies.
Pathogens including Shigella dysenteriae utilize cytoskeletal
rearrangement in order to gain entry inside host cells (Rottner
et al., 2005). However, each pathogen utilizes unique mechanism
to invade immune cells. We observed that internalization of
P. aeruginosa inside human MDM and mouse BMMφ relies
on both microfilament and microtubule dependent uptake
mechanisms. Pretreatment of human MDMs and mouse
BMMφ with actin polymerization inhibitors or microtubule-
destabilizing agents led to a significant decrease in invasion of
macrophages by P. aeruginosa in a dose-dependent manner.
Some pathogens utilize only microfilaments whereas others
employ microfilaments to gain entry inside host cells that
are also cell type specific (Oelschlaeger et al., 1993; Kopecko
et al., 2001; Mazon Moya et al., 2014; Valencia-Gallardo
et al., 2015). However, the entry of other pathogens requires
both microfilament and microtubule dependent uptake
mechanisms (Ferrero et al., 2009; Taylor et al., 2010) as
observed for otopathogenic P. aeruginosa in the present
study.
Pathogens employ various strategies in order to survive inside
the host and cause infection. Some pathogens trigger anti-
apoptotic mechanisms to prevent host cell death. Pathogens
including Enterococcus faecalis, Toxoplasma gondii, Brucella
sp., Neisseria meningitidis, and Neisseria gonorrhoeae inhibit
apoptosis of host cells, providing a niche where they can
survive and replicate (Beck and Meyer, 2000; Tunbridge
et al., 2006; Cai et al., 2014; Cui et al., 2014; Zou and
Shankar, 2014). On the contrary, other microbes including
Mycobacterium tuberculosis, Legionella pneumophila, Bordetella
pertussis, Listeria monocytogenes, Corynebacterium diphtheriae,
Shigella flexneri, and Salmonella typhimurium, induces cell
death that allow the pathogens to efficiently exit the host cell,
spread to neighboring cells, evade immune cells, and/or to gain
nutrients (Haimovich and Venkatesan, 2006; Hewlett et al.,
2006; Cervantes et al., 2008; dos Santos et al., 2010; Morinaga
et al., 2010; Welin et al., 2011; Ashida et al., 2014; Behnsen
et al., 2015). Thus, knowledge of the mechanisms employed
by pathogens in the progression of disease is critical to have
a better understanding of virulence and host defense. In this
study, we observed that otopathogenic P. aeruginosa induces
death of human MDMs and mouse BMMφ as determined by
LDH release in the cell culture supernatants and ethidium
homodimer-I staining. LDH is the most acceptable and reliable
marker for determining host cell death (Kwon et al., 2015;
Park et al., 2015; Lv et al., 2016). Ethidium homodimer-I
is a fluorescent nuclear stain that penetrates dead cells due
to disrupted plasma membrane and increases intensity after
binding to DNA (Eidet et al., 2015; McCanna et al., 2015;
Yoeruek et al., 2016). The ability of otopathogenic P. aeruginosa
to induce cell death in macrophages enables this pathogen
to escape potent host defenses and will enable it to cause
infection.
In summary, the results presented here demonstrate for
the first time that otopathogenic P. aeruginosa are able to
enter and survive inside macrophages in context of ear
infections. Studies are in progress in our laboratory to elucidate
the molecular mechanisms through which otopathogenic
P. aeruginosa escape from macrophage killing. The uptake of
otopathogenic P. aeruginosa by human MDMs and mouse
BMMφ relies on actin polymerization and microtubule
dependent process. Bacterial OprF expression plays a crucial
role in the intracellular survival of P. aeruginosa inside human
MDMs and mouse BMMφ. Future studies comparing the
level of oprF gene expression between strains isolated from
CSOM patients and the other diseases such as pneumonia or
urinary infection will help in confirming the role of bacterial
oprF for the establishment of CSOM. In addition, it has
been demonstrated that pathogens form biofilms on middle
ear during CSOM (Saunders J.E. et al., 2011; Kaya et al.,
2013; Gu et al., 2014). Therefore, future investigations are
warranted to determine the interaction of biofilm cells of
otopathogenic P. aeruginosa with primary macrophages. Our
findings suggest that otopathogenic P. aeruginosa is recognized
by phagocytic cells but remain impermeable to attacks by their
antimicrobial components and is able to exert cytotoxic effects
on macrophages. Further studies employing mouse model of
CSOM are warranted to delineate the role of macrophages in the
disease process. Understanding host–pathogen interactions will
provide novel avenues to design effective treatment modalities
Frontiers in Microbiology | www.frontiersin.org 11 November 2016 | Volume 7 | Article 1828
fmicb-07-01828 November 16, 2016 Time: 14:6 # 12
Mittal et al. Interaction of Otopathogenic P. aeruginosa with Macrophages
against CSOM, and hence, prevent consequent hearing loss as
well as life-threatening CNS complications.
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